
51 - 200 funcionários
Fundada em 2019
🧬 Biotecnologia
💊 Farmacêutico
💰 $90.000.000 Debt Financing - Secura Bio em 2019-03
Biotechnology • Pharmaceuticals
Secura Bio, Inc. é uma empresa biofarmacêutica em fase comercial focada no desenvolvimento, comercialização e otimização de terapias oncológicas. A empresa enfatiza a estratégia comercial e o acesso ao mercado para medicamentos oncológicos, apoiada por capacidades de desenvolvimento clínico (ensaios clínicos, acesso expandido, estudos patrocinados por investigadores), educação médica e programas de apoio ao paciente. Sediada em Berkeley Heights, Nova Jersey, com um escritório em Dublin, Irlanda, a Secura Bio se posiciona para maximizar os resultados comerciais para tratamentos de câncer como duvelisib.
🕒 Março 24
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2019
🧬 Biotecnologia
💊 Farmacêutico
💰 $90.000.000 Debt Financing - Secura Bio em 2019-03
Biotechnology • Pharmaceuticals
Secura Bio, Inc. é uma empresa biofarmacêutica em fase comercial focada no desenvolvimento, comercialização e otimização de terapias oncológicas. A empresa enfatiza a estratégia comercial e o acesso ao mercado para medicamentos oncológicos, apoiada por capacidades de desenvolvimento clínico (ensaios clínicos, acesso expandido, estudos patrocinados por investigadores), educação médica e programas de apoio ao paciente. Sediada em Berkeley Heights, Nova Jersey, com um escritório em Dublin, Irlanda, a Secura Bio se posiciona para maximizar os resultados comerciais para tratamentos de câncer como duvelisib.
• Lead the development and execution of Medical Affairs aligned HEOR and real-world evidence (RWE) data generation for hematologic oncology assets across prelaunch and postlaunch phases. • Lead and identify evidence gaps relevant to clinical practice, treatment pathways, and patient outcomes in hematologic malignancies (e.g., lymphoma, leukemia, multiple myeloma). • Provide strategic input into Medical Affairs plans, including integrated evidence generation and scientific communication strategies. • Design and oversee observational studies, registries, chart reviews, and other RWE initiatives relevant to hematologic oncology populations. • Partner with Clinical and Biostatistics teams to ensure alignment between clinical trial data and RWE generation. • Oversee the development and interpretation of health economic analyses (e.g., cost effectiveness, burden of illness, healthcare resource utilization) to contextualize clinical benefit in hematologic oncology. • Ensure economic and outcomes evidence is scientifically rigorous, clinically meaningful, and suitable for external scientific exchange under Medical Affairs standards. • Collaborate cross functionally to ensure consistency of value messaging while maintaining Medical Affairs independence and compliance. • Lead or support the development of HEOR related abstracts, posters, manuscripts, and congress submissions in hematologic oncology. • Serve as a Medical Affairs HEOR subject matter expert to support MSL training, scientific platforms, and field medical needs. • Support compliant scientific exchange with external experts, cooperative groups, and other stakeholders on outcomes and RWE. • Work closely with Medical Directors, Clinical Development, Market Access, and Regulatory colleagues to ensure integrated and nonpromotional evidence planning. • Manage external vendors and academic collaborators to ensure high quality execution of HEOR studies. • Oversee timelines, deliverables, and budgets for assigned HEOR initiatives.
• Advanced degrees (PhD, DrPH, ScD, MD, PharmD), with experience in health economics, outcomes research, epidemiology, public health, health services research, or related fields. • 4-6+ years of experience in HEOR, outcomes research, or RWE within pharmaceutical, biotech, consulting, or academic environments. • Candidates with advanced scientific degrees may be considered with fewer years of industry experience. • First-hand experience executing site-based non-interventional studies, systematic literature reviews, claims / administrative database analysis, patient-reported outcomes and health economic modeling. • Ability to translate complex data into clinically relevant insights for scientific audiences. • Experience with scientific publications and congress presentations. • Strong cross functional collaboration and project management skills. • High standards for scientific rigor, compliance, and Medical Affairs independence. • Experience in Global dossier preparation (preferably EU region). • Prior experience in hematologic oncology or closely related oncology settings is strongly preferred. • Demonstrated experience supporting Medical Affairs or clinical focused evidence generation. • Experience supporting cross-functional internal stakeholders. • Familiarity with treatment landscape of treatment and evolving standards of care in hematologic malignancies. • Strong entrepreneurial spirit who can work independently and proactively. • Experience working across global or regional Medical Affairs organizations.
Candidatar-se🕒 Março 24
Senior Manager/Associate Director, Biostatistics at Codera providing statistical expertise in drug development. Collaborating on clinical programs and ensuring quality control of statistical deliverables.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Março 23
Senior Director of Strategy driving Veeva's Clinical Trial Management System adoption. Leading market growth and strategy for life sciences companies with a focus on execution and customer engagement.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $150.000 - $300.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Março 23
Senior Director of Strategy at Veeva driving Clinical Trial Management System adoption for life sciences companies with deep strategy and commercial execution.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $150.000 - $300.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Março 23
Senior Director of Strategy focusing on Veeva's CTMS market adoption and growth in life sciences. Collaborating cross-functionally to enhance product and drive customer success.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $150.000 - $300.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Março 23
Senior Director leading strategy, execution, and market acceleration for zero-emission trucks at CALSTART. Collaborating with industry and government to drive market effective technologies and policies.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $140.000 - $177.960 / ano
💰 Grant em 2022-01
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório